IIT, Hyderabad-incubated Startup BeAble wins Rs 25 lakh funding at ‘Open Innovation Challenge 2019′

ArmAble, BeAble Health’s product is aimed at solving pressing need for an intensive, engaging and regular rehabilitation therapy for upper limb

Indian Institute of Technology, Hyderabad-incubated Startup BeAble won Rs 25 lakh in funding at ‘Open Innovation Challenge 2019’ of India Innovation Growth Programme (IIGP) 2.0. The startup is a spinoff from the first batch of Fellowship in Healthcare Entrepreneurship at Center for Healthcare Entrepreneurship (CfHE) IIT, Hyderabad and works in the convergence of good design and technology to rehabilitate stroke patients.

The IIGP 2.0 Open Innovation Challenge 2019 received more than 1,600 applications from across India. BeAble Health was selected as one of the winners and awarded seed grant of Rs 25 lakh to support its market penetration and scale-up operations.

Congratulating BeAble on its success, Prof Renu John, Co-Head, CfHE and Head, Department of Biomedical Engineering, IIT, Hyderabad, said, “The Center for Healthcare Entrepreneurship (CfHE), IIT, Hyderabad, is focussed entirely on boosting healthcare innovation in India. BeAble is one such example of an innovative startup coming out from the CfHE and we are sure they will make a positive impact on Indian healthcare sector. IIT, Hyderabad looks forward to incubating many more successful startups through CfHE.”

‘ArmAble’ is BeAble Health’s first product and is aimed at solving the pressing need for an intensive, engaging and regular rehabilitation therapy for upper limb. It is aimed at conditions such as cerebral palsy, multiple sclerosis, traumatic brain injury, fracture and frozen shoulder. The key features of ‘ArmAble’ device include:

• Affordable
• Engaging Game-Based Therapy
• Higher Repetitions and Intensity
• Data based quantified progress and recovery
• Full ROM for the Arms
• Tele-Rehabilitation

Highlighting the impact this seed grant will have on the startup, Habib Ali, Founder and Chief Executive Officer, BeAble said, “IIGP 2.0 has put BeAble Health in a position which allows us to aggressively pursue our targets. The seed granted will accelerate our pilot production.”

Further, speaking about the targets for BeAble, Ali said, “We aim to deploy around 100 devices in the coming year, which involves both sales and rent. This will allow us to deliver more than 1 lakh hours of therapy impacting the lives of many.”